Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility".
Press Release Dec 22 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release Dec 09 2022
- Press Release Dec 01 2022
- Press Release Nov 21 2022
- Press Release Nov 14 2022
- Press Release Nov 03 2022
Later from Alembic Pharmaceuticals
- Press Release Dec 26 2022
- Press Release Jan 06 2023
- Press Release Jan 19 2023
- Press Release Mar 01 2023
- Alembic Pharmaceuticals Limited Press Release Mar 06 2023
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals